Re: Dallas

The matter of *Re: Dallas* concerned an application brought before the court regarding the medical treatment of a child, identified as Dallas (formerly “A”). The central dispute revolved around the child's capacity to consent to specific medical treatment.

The primary legal issue before the court was whether Dallas was Gillick Competent to consent to 'Phase 2' testosterone hormone therapy treatment. This required the court to assess the child's understanding and maturity in relation to the proposed medical intervention.

The court's reasoning, though not detailed in the provided text, led to the determination that Dallas was indeed Gillick Competent. Consequently, the court made orders declaring the child Gillick Competent to consent to the specified treatment. Furthermore, extensive orders were made to protect the anonymity of the child, their family, medical practitioners, school, and all other identifying details, ensuring that only anonymised reasons for judgment and orders would be released to non-parties. Access to the court file was also restricted, requiring judicial leave for any searches.